Clinical Trial

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

Study acronym: FUN-CD
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn about the effects of fluconazole in patients who plan to start or are currently undergoing standard of care treatment and plan to dose-escalate an IL-23 therapy for their Crohn's disease. The main question it aims to assess is whether or not patient response to IL-23 therapies improve when simultaneously treated with fluconazole.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-15; most recent amendment 2025-09-29.
Status change: Not Yet Recruiting → Recruiting 2024-10-24
Trial Details
NCT Number NCT06274554
Lead Sponsor Weill Medical College of Cornell University
Collaborators: The Leona M. and Harry B. Helmsley Charitable Trust
Conditions Crohn's Disease, Inflammatory Bowel Diseases
Enrollment 120 participants
Start Date 2024-10-04
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-01